药品名称ANECTINE
申请号008453产品号001
活性成分SUCCINYLCHOLINE CHLORIDE市场状态停止上市
剂型或给药途径INJECTABLE;INJECTION规格500MG/VIAL
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构SANDOZ CANADA INC
化学类型New molecular entity (NME)审评分类Priority review drug
与本品相关的专利信息(来自橙皮书Orange Book)
专利号专利过期日是否化合物专利是否产品专利专利用途代码专利下载
历史专利信息
与本品相关的市场独占权保护信息
独占权代码失效日期
历史市场独占权保护信息
与药品注册相关的信息
申请号修订号审批结论公开文档类型文档创建时间获取文档
008453027APLabel2010/11/22下载
008453027APLetter2010/11/30下载
008453012APReview2000/06/12下载
008453006APReview2000/06/12下载
008453004APReview2000/06/12下载
008453001APReview2000/06/12下载
药品注册审批历史信息
申请号修订号审批结论审批日期审批内容
008453032AP2016/01/25Manufacturing Change or Addition
008453030AP2013/01/17Manufacturing Change or Addition
008453027AP2010/11/22Labeling Revision
008453019AP2000/10/02Labeling Revision
008453018AP1997/04/10Manufacturing Change or Addition
008453017AP1994/11/28Labeling Revision
008453016AP2000/09/26Labeling Revision
008453015AP1993/10/29Labeling Revision
008453014AP1987/11/10Labeling Revision
008453013AP1985/05/01Labeling Revision
008453012AP1982/02/11Package Change
008453011AP1981/05/15Control Supplement
008453010AP1981/02/12Control Supplement
008453009AP1981/12/22Labeling Revision
008453008AP1980/11/21Control Supplement
008453007AP1985/05/22Formulation Revision
008453006AP1978/03/30Control Supplement
008453004AP1975/12/05Labeling Revision
008453001AP1973/06/22Final Printed Labeling - MarkIV
008453000AP1952/08/20Approval